Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies
Conditioning regimens play a crucial role in preventing relapse of acute myeloid leukemia (AML) following allogeneic hematopoietic cell transplantation (HCT). In early times, myeloablative conditioning was used exclusively, but it was associated with significant toxicity. However, the advent of redu...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1050633/full |
| _version_ | 1797986958281015296 |
|---|---|
| author | Masamitsu Yanada Kaito Harada Yoshimitsu Shimomura Yasuyuki Arai Takaaki Konuma |
| author_facet | Masamitsu Yanada Kaito Harada Yoshimitsu Shimomura Yasuyuki Arai Takaaki Konuma |
| author_sort | Masamitsu Yanada |
| collection | DOAJ |
| description | Conditioning regimens play a crucial role in preventing relapse of acute myeloid leukemia (AML) following allogeneic hematopoietic cell transplantation (HCT). In early times, myeloablative conditioning was used exclusively, but it was associated with significant toxicity. However, the advent of reduced-intensity conditioning has allowed allogeneic HCT to be performed more safely, leading to an expansion of our choices for conditioning regimens. As the transplantation methods have become highly diversified, it is reasonable to determine an optimal conditioning regimen in consideration of patient-, disease-, and transplantation-related factors. In this context, large-scale registry-based studies provide real-world data to allow for a detailed evaluation of the utility of individual conditioning regimens in specific clinical settings. The Japanese Society for Transplantation and Cellular Therapy has been conducting a nationwide survey for HCT since 1993 that currently covers >99% of all the transplantation centers nationwide, and >1,000 allogeneic HCTs performed for adults with AML are registered per year. We have been using the registry data to implement a number of studies focusing on adults with AML, and the large number of patients registered consecutively from nearly all transplantation centers nationwide represent real-world practice in Japan. This article reviews and discusses the results obtained from our registry-based studies pertaining to various conditioning regimens. |
| first_indexed | 2024-04-11T07:40:10Z |
| format | Article |
| id | doaj.art-e0a1ab05004f4125b6c007308ce9072c |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-04-11T07:40:10Z |
| publishDate | 2022-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-e0a1ab05004f4125b6c007308ce9072c2022-12-22T04:36:36ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.10506331050633Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studiesMasamitsu Yanada0Kaito Harada1Yoshimitsu Shimomura2Yasuyuki Arai3Takaaki Konuma4Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, JapanDepartment of Hematology and Oncology, Tokai University School of Medicine, Isehara, JapanDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, JapanDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, JapanDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, JapanConditioning regimens play a crucial role in preventing relapse of acute myeloid leukemia (AML) following allogeneic hematopoietic cell transplantation (HCT). In early times, myeloablative conditioning was used exclusively, but it was associated with significant toxicity. However, the advent of reduced-intensity conditioning has allowed allogeneic HCT to be performed more safely, leading to an expansion of our choices for conditioning regimens. As the transplantation methods have become highly diversified, it is reasonable to determine an optimal conditioning regimen in consideration of patient-, disease-, and transplantation-related factors. In this context, large-scale registry-based studies provide real-world data to allow for a detailed evaluation of the utility of individual conditioning regimens in specific clinical settings. The Japanese Society for Transplantation and Cellular Therapy has been conducting a nationwide survey for HCT since 1993 that currently covers >99% of all the transplantation centers nationwide, and >1,000 allogeneic HCTs performed for adults with AML are registered per year. We have been using the registry data to implement a number of studies focusing on adults with AML, and the large number of patients registered consecutively from nearly all transplantation centers nationwide represent real-world practice in Japan. This article reviews and discusses the results obtained from our registry-based studies pertaining to various conditioning regimens.https://www.frontiersin.org/articles/10.3389/fonc.2022.1050633/fullacute myeloid leukemiaallogeneic hematopoietic cell transplantationconditioning regimenmyeloablative conditioningreduced-intensity conditioning |
| spellingShingle | Masamitsu Yanada Kaito Harada Yoshimitsu Shimomura Yasuyuki Arai Takaaki Konuma Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies Frontiers in Oncology acute myeloid leukemia allogeneic hematopoietic cell transplantation conditioning regimen myeloablative conditioning reduced-intensity conditioning |
| title | Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies |
| title_full | Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies |
| title_fullStr | Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies |
| title_full_unstemmed | Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies |
| title_short | Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies |
| title_sort | conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia real world data from the japanese registry studies |
| topic | acute myeloid leukemia allogeneic hematopoietic cell transplantation conditioning regimen myeloablative conditioning reduced-intensity conditioning |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.1050633/full |
| work_keys_str_mv | AT masamitsuyanada conditioningregimensforallogeneichematopoieticcelltransplantationinacutemyeloidleukemiarealworlddatafromthejapaneseregistrystudies AT kaitoharada conditioningregimensforallogeneichematopoieticcelltransplantationinacutemyeloidleukemiarealworlddatafromthejapaneseregistrystudies AT yoshimitsushimomura conditioningregimensforallogeneichematopoieticcelltransplantationinacutemyeloidleukemiarealworlddatafromthejapaneseregistrystudies AT yasuyukiarai conditioningregimensforallogeneichematopoieticcelltransplantationinacutemyeloidleukemiarealworlddatafromthejapaneseregistrystudies AT takaakikonuma conditioningregimensforallogeneichematopoieticcelltransplantationinacutemyeloidleukemiarealworlddatafromthejapaneseregistrystudies |